|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Additional conditions recognized in this trial | ||||
| Hydrocephalus | |||||
| Hydrocephalus, Normal Pressure | |||||
| 2 | More general conditions related to this trial | ||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Infant, Newborn, Diseases | |||||
| Intracranial Hypertension | |||||
| Nervous System Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| ventriculo-peritoneal shunt | |||||
| 4 | Sponsors listed in this trial | ||||
| Translational Research Informatics Center, Kobe, Hyogo, Japan | |||||
| Codman &Shurtleff | |||||
| Johnson &Johnson | |||||
| NIHON MEDI-PHYSICS CO.,LTD. | |||||
| Daiichi Pharmaceuticals | |||||
| Eisai Limited | |||||